BioCryst Pharmaceuticals | BCRX - Capitale Ordinario

Prezzo Delle Azioni
9.78
Cambio Giornaliero
0.08 0.82%
Mensile
28.52%
Annuale
21.49%
Q1 Previsione
9.41




Capitale Ordinario Cambiamento Data
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
BioCryst Pharmaceuticals USD 213.06M 2.54M 2025-12
Chugai Pharma JPY 1.65B 8K 2025-12
Daiichi Sankyo JPY 1.85B 9K 2025-12
DBV Technologies USD 136.82M 51.98K 2025-09
Enanta Pharmaceuticals USD 212K 1000 2023-12
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Glaxosmithkline GBP 4.08B 49.43M 2025-12
Incyte USD 198.46M 2.33M 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
Karyopharm Therapeutics USD 13K 0 2024-09
Neurocrine Biosciences USD 100.1M 400K 2025-12
Novavax USD 162.58M 106K 2025-12
PTC Therapeutics USD 81.47M 1.54M 2025-12
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.96M 196K 2025-12
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vertex Pharmaceuticals USD 254M 0 2025-12